How do you approach brain SRS for patients currently receiving Trastuzumab deruxtecan with progressive brain lesions?  

Is there a certain amount of time that you prefer to have elapsed after the last infusion before delivering SRS? Do you avoid all subsequent Trastuzumab deruxtecan (Enhertu) after delivering SRS? 



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice